Literature DB >> 3472246

Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine.

K Ueda, C Cardarelli, M M Gottesman, I Pastan.   

Abstract

Intrinsic and acquired multidrug resistance (MDR) is an important problem in cancer therapy. MDR in human KB carcinoma cells selected for resistance to colchicine, vinblastine, or doxorubicin (former generic name adriamycin) is associated with overexpression of the "MDR1" gene, which encodes P-glycoprotein. We previously have isolated an overlapping set of cDNA clones for the human MDR1 gene from multidrug-resistant KB cells. Here we report the construction of a full-length cDNA for the human MDR1 gene and show that this reconstructed cDNA, when inserted into a retroviral expression vector containing the long terminal repeats of Moloney leukemia virus or Harvey sarcoma virus, functions in mouse NIH 3T3 and human KB cells to confer the complete multidrug-resistance phenotype. These results suggest that the human MDR1 gene may be used as a positive selectable marker to introduce genes into human cells and to transform human cells to multidrug resistance without introducing nonhuman antigens.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3472246      PMCID: PMC304789          DOI: 10.1073/pnas.84.9.3004

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter.

Authors:  D A Melton; P A Krieg; M R Rebagliati; T Maniatis; K Zinn; M R Green
Journal:  Nucleic Acids Res       Date:  1984-09-25       Impact factor: 16.971

2.  Amplification of specific DNA sequences correlates with multi-drug resistance in Chinese hamster cells.

Authors:  I B Roninson; H T Abelson; D E Housman; N Howell; A Varshavsky
Journal:  Nature       Date:  1984 Jun 14-20       Impact factor: 49.962

3.  Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines.

Authors:  J R Riordan; K Deuchars; N Kartner; N Alon; J Trent; V Ling
Journal:  Nature       Date:  1985 Aug 29-Sep 4       Impact factor: 49.962

4.  DNA-mediated transfer of multiple drug resistance and plasma membrane glycoprotein expression.

Authors:  P G Debenham; N Kartner; L Siminovitch; J R Riordan; V Ling
Journal:  Mol Cell Biol       Date:  1982-08       Impact factor: 4.272

5.  Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.

Authors:  N T Bech-Hansen; J E Till; V Ling
Journal:  J Cell Physiol       Date:  1976-05       Impact factor: 6.384

6.  Dual evolutionary origin for the rat genetic sequences of Harvey murine sarcoma virus.

Authors:  R W Ellis; D DeFeo; J M Maryak; H A Young; T Y Shih; E H Chang; D R Lowy; E M Scolnick
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

7.  Active efflux of daunorubicin and adriamycin in sensitive and resistant sublines of P388 leukemia.

Authors:  M Inaba; H Kobayashi; Y Sakurai; R K Johnson
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

8.  Reduced drug accumulation in multiply drug-resistant human KB carcinoma cell lines.

Authors:  A Fojo; S Akiyama; M M Gottesman; I Pastan
Journal:  Cancer Res       Date:  1985-07       Impact factor: 12.701

9.  Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.

Authors:  N Kartner; J R Riordan; V Ling
Journal:  Science       Date:  1983-09-23       Impact factor: 47.728

10.  Increased accumulation of vincristine and adriamycin in drug-resistant P388 tumor cells following incubation with calcium antagonists and calmodulin inhibitors.

Authors:  T Tsuruo; H Iida; S Tsukagoshi; Y Sakurai
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

View more
  247 in total

1.  MDR1 genotype-related pharmacokinetics of digoxin after single oral administration in healthy Japanese subjects.

Authors:  T Sakaeda; T Nakamura; M Horinouchi; M Kakumoto; N Ohmoto; T Sakai; Y Morita; T Tamura; N Aoyama; M Hirai; M Kasuga; K Okumura
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

Review 2.  The oral route for the administration of cytotoxic drugs: strategies to increase the efficiency and consistency of drug delivery.

Authors:  H A Bardelmeijer; O van Tellingen; J H Schellens; J H Beijnen
Journal:  Invest New Drugs       Date:  2000-08       Impact factor: 3.850

3.  P-glycoprotein expression in soft-tissue sarcomas.

Authors:  H Nakanishi; A Myoui; T Ochi; K Aozasa
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

4.  Identification of a putatively multixenobiotic resistance related Abcb1 transporter in amphipod species endemic to the highly pristine Lake Baikal.

Authors:  Vasiliy V Pavlichenko; Marina V Protopopova; Maxim Timofeyev; Till Luckenbach
Journal:  Environ Sci Pollut Res Int       Date:  2014-11-05       Impact factor: 4.223

5.  Regulation of P-glycoprotein gene expression in hepatocyte cultures and liver cell lines by a trans-acting transcriptional repressor.

Authors:  T W Gant; J A Silverman; S S Thorgeirsson
Journal:  Nucleic Acids Res       Date:  1992-06-11       Impact factor: 16.971

6.  The multiple drug resistance gene, MDR1: expression at the protein and RNA levels.

Authors:  Y Q Li; V Gopal; P Kadam; S Files; H Preisler
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

Review 7.  Genetic aspects of multidrug resistance.

Authors:  M Pauly; F Ries; M Dicato
Journal:  Med Oncol Tumor Pharmacother       Date:  1992

8.  Polymorphism C3435T of the MDR1 gene in Central Americans and Spaniards.

Authors:  J Vicente; Blanca Sinues; A Fanlo; P Vasquez; J C Medina; B Martinez-Jarreta
Journal:  Mol Biol Rep       Date:  2007-06-19       Impact factor: 2.316

9.  Effect of cyclosporin A on daunorubicin accumulation in multidrug-resistant P388 leukemia cells measured by real-time flow cytometry.

Authors:  K Nooter; R Oostrum; R Jonker; H van Dekken; W Stokdijk; G van den Engh
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

10.  Selective toxicity of NSC73306 in MDR1-positive cells as a new strategy to circumvent multidrug resistance in cancer.

Authors:  Joseph A Ludwig; Gergely Szakács; Scott E Martin; Benjamin F Chu; Carol Cardarelli; Zuben E Sauna; Natasha J Caplen; Henry M Fales; Suresh V Ambudkar; John N Weinstein; Michael M Gottesman
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.